Position in ICLR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$776,161,641
+$294,644,902 QoQ
Shares Held
4,468,146
+2.7% QoQ
Ownership
5.79%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#5
of 422 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HARRIS ASSOCIATES L P holds $3,646,085,562 across 6 Diagnostics & Research names. ICLR ranks #2 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
12,183,830 | $2,354,159,631 | |
| 2 | ICLR |
Icon PLC
This page
|
4,468,146 | $776,161,641 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
2,241,144 | $508,269,047 | |
| 4 | WAT |
Waters Corp /De/
|
18,413 | $6,905,611 | |
| 5 | DHR |
Danaher Corp /De/
|
1,838 | $350,102 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
455 | $239,530 |
All Filings in ICLR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $776,161,641 | 4,468,146 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $481,516,739 | 4,351,317 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $457,402,448 | 2,510,166 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $409,947,825 | 2,342,559 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $238,255,681 | 1,638,059 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||